Author

Giorgia Bodini

UPDATED OVERVIEW OF CLINICAL CHARACTERISTICS AND UNDERLYING CAUSES OF DYSPHAGIA IN THE OUTPATIENT SETTING: REAL-LIFE EXPERIENCE FROM A TERTIARY CENTRE
UPDATED OVERVIEW OF CLINICAL CHARACTERISTICS AND UNDERLYING CAUSES OF DYSPHAGIA IN THE OUTPATIENT SETTING: REAL-LIFE EXPERIENCE FROM A TERTIARY CENTRE

Giorgia Bodini  et al.

EFFECT OF HIATAL HERNIA AND ESOPHAGOGASTRIC JUNCTION MORPHOLOGY ON OESOPHAGEAL MOTILITY. NEW EVIDENCES FROM HIGH RESOLUTION MANOMETRY
EFFECT OF HIATAL HERNIA AND ESOPHAGOGASTRIC JUNCTION MORPHOLOGY ON OESOPHAGEAL MOTILITY. NEW EVIDENCES FROM HIGH RESOLUTION MANOMETRY

Giorgia Bodini  et al.

ASSOCIATION BETWEEN ESOPHAGEAL MOTOR DISORDERS AND PULMONARY INVOLVEMENT IN PATIENTS AFFECTED BY SYSTEMIC SCLEROSIS: A RETROSPECTIVE STUDY
ASSOCIATION BETWEEN ESOPHAGEAL MOTOR DISORDERS AND PULMONARY INVOLVEMENT IN PATIENTS AFFECTED BY SYSTEMIC SCLEROSIS: A RETROSPECTIVE STUDY

Giorgia Bodini  et al.

IMPACT OF ENVIRONMENTAL CHANGES FORCED BY PANDEMIC RESTRICTIVE MEASURES ON THE DEVELOPMENT AND COURSE OF IRRITABLE BOWEL SYNDROME
IMPACT OF ENVIRONMENTAL CHANGES FORCED BY PANDEMIC RESTRICTIVE MEASURES ON THE DEVELOPMENT AND COURSE OF IRRITABLE BOWEL SYNDROME

Giorgia Bodini  et al.

THE ANTI IL-23/IL-12 AGENT USTEKINUMAB IS AN EFFECTIVE AND SAFE INDUCTION THERAPY IN PATIENTS WITH CROHN'S DISEASE REFRACTORY OR INTOLERANT TO ANTI-TNF: A MULTICENTRE ITALIAN STUDY
THE ANTI IL-23/IL-12 AGENT USTEKINUMAB IS AN EFFECTIVE AND SAFE INDUCTION THERAPY IN PATIENTS WITH CROHN'S DISEASE REFRACTORY OR INTOLERANT TO ANTI-TNF: A MULTICENTRE ITALIAN STUDY

Giorgia Bodini  et al.

SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)
SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)

Giorgia Bodini  et al.

REDUCED HUMORAL RESPONSE TO TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE-IBD, AN IG-IBD STUDY
REDUCED HUMORAL RESPONSE TO TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE-IBD, AN IG-IBD STUDY

Giorgia Bodini  et al.

REAL-LIFE EVALUATION OF GOLIMUMAB EFFECTIVENESS AND QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: THE PROSPECTIVE GO-CARE STUDY
REAL-LIFE EVALUATION OF GOLIMUMAB EFFECTIVENESS AND QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: THE PROSPECTIVE GO-CARE STUDY

Giorgia Bodini  et al.

Item 1 - 8 / 8
1